Allero Therapeutics develops next generation immunotherapies for allergic and autoimmune disease patients. Its proprietary SOMIT (Specific OroMucosal ImmunoTherapy) technology is designed to induce long-lasting antigen-specific tolerance.
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Curie Capi... | curiecapit... |
| - | Swanbridge... | swanbridge... |
Mentions in press and media 1
| Date | Title | Description |
| 22.12.2021 | Largest-ever funding round from EIC Accelerator: EC selects 99 startups to receive €627M; meet the 10 Dutch startups selected | The European Commission has announced the selection of 99 innovative startups and SMEs to be funded under the European Innovation Council (EIC) Accelerator programme. The selected startups will receive €627M of EU funding to help them bring... |